Additional Local Therapy for Liver Metastases in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Systemic PSMA-Targeted Therapy

Robert Seifert; Katharina Kessel; Martin Boegemann; Michael Köhler; Wolfgang Roll; Lars Stegger; Matthias Weckesser; Kambiz Rahbar

doi:10.2967/jnumed.119.233429

Research ArticleTheranostics

Additional Local Therapy for Liver Metastases in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Systemic PSMA-Targeted Therapy

Robert Seifert, Katharina Kessel, Martin Boegemann, Michael Köhler, Wolfgang Roll, Lars Stegger, Matthias Weckesser and Kambiz Rahbar

Journal of Nuclear Medicine May 2020, 61 (5) 723-728; DOI: https://doi.org/10.2967/jnumed.119.233429

Robert Seifert

1Department of Nuclear Medicine, University Hospital Münster, Münster, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Katharina Kessel

1Department of Nuclear Medicine, University Hospital Münster, Münster, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Martin Boegemann

2Department of Urology, University Hospital Münster, Münster, Germany; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Michael Köhler

3Department of Clinical Radiology, University Hospital Münster, Münster, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Wolfgang Roll

1Department of Nuclear Medicine, University Hospital Münster, Münster, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Lars Stegger

1Department of Nuclear Medicine, University Hospital Münster, Münster, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Matthias Weckesser

1Department of Nuclear Medicine, University Hospital Münster, Münster, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Kambiz Rahbar

1Department of Nuclear Medicine, University Hospital Münster, Münster, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Data supplements

Supplemental Data

Files in this Data Supplement:

Supplemental Data

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 61, Issue 5

May 1, 2020

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Additional Local Therapy for Liver Metastases in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Systemic PSMA-Targeted Therapy

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Additional Local Therapy for Liver Metastases in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Systemic PSMA-Targeted Therapy

Robert Seifert, Katharina Kessel, Martin Boegemann, Michael Köhler, Wolfgang Roll, Lars Stegger, Matthias Weckesser, Kambiz Rahbar

Journal of Nuclear Medicine May 2020, 61 (5) 723-728; DOI: 10.2967/jnumed.119.233429

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Additional Local Therapy for Liver Metastases in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Systemic PSMA-Targeted Therapy

Robert Seifert, Katharina Kessel, Martin Boegemann, Michael Köhler, Wolfgang Roll, Lars Stegger, Matthias Weckesser, Kambiz Rahbar

Journal of Nuclear Medicine May 2020, 61 (5) 723-728; DOI: 10.2967/jnumed.119.233429

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

This Month in JNM

PubMed
Google Scholar

Cited By...

Is 18F-FDG PET Needed to Assess 177Lu-PSMA Therapy Eligibility? A VISION-like, Single-Center Analysis

Google Scholar

Theranostics

Can ¹⁷⁷Lu-DOTATATE Kidney Absorbed Doses be Predicted from Pretherapy SSTR PET? Findings from Multicenter Data
Evidence-Based Clinical Protocols to Monitor Efficacy of [¹⁷⁷Lu]Lu-PSMA Radiopharmaceutical Therapy in Metastatic Castration-Resistant Prostate Cancer Using Real-World Data
¹⁷⁷Lu-Labeled Anticlaudin 6 Monoclonal Antibody for Targeted Therapy in Esophageal Cancer

Show more Theranostics

Clinical

Addition of ¹³¹I-MIBG to PRRT (⁹⁰Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors
SUVs Are Adequate Measures of Lesional ¹⁸F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden
Hypermetabolism on Pediatric PET Scans of Brain Glucose Metabolism: What Does It Signify?

Show more Clinical

Keywords

PSMA
prostate cancer
SIRT

Main menu

User menu

Search

Additional Local Therapy for Liver Metastases in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Systemic PSMA-Targeted Therapy

Data supplements

Supplemental Data

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Theranostics

Clinical

Similar Articles

Keywords